COVID-19
Pharmafile.com’s weekly COVID-19 news round-up
August 12, 2020Research and Development COVID-19, coronavirus, covid news
The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …
Gilead applies for FDA approval to treat coronavirus patients with remdesivir
August 11, 2020Manufacturing and Production COVID-19, Gilead, coronavirus
Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients. The drug would go under …
Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine
August 11, 2020Manufacturing and Production COVID, COVID-19, Vaccine, coronavirus
President Putin has announced that Russia is the first country to grant regulatory approval for a COVID-19 vaccine. The final …
Over 100 Americans have died after taking hydroxychloroquine in the first half of 2020
August 10, 2020Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine
More than 100 Americans have died after taking the drug hydroxychloroquine to treat or prevent coronavirus. This was found in …
Over a third of Americans say they won’t take a coronavirus vaccine
August 10, 2020Sales and Marketing COVID-19, coronavirus, vaccines
35% of Americans say they have no plans to take a COVID-19 vaccine, according to new polling. A new Gallup …
Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions
August 10, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine
Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …
Early promise from Novavax’s vaccine candidate for COVID-19
August 7, 2020Medical Communications, Research and Development COVID-19, Novavax, Vaccine
New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …
AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China
August 7, 2020Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, China, pharma
AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …
Top Ten most popular articles on Pharmafile.com this week
August 7, 2020Medical Communications COVID-19, Top 10 news, top 10
The top ten news stories this week are dominated by corporate scandals, with researchers finding that Coca-Cola paid an organisation …
US to pay Johnson and Johnson $1 billion for COVID-19 vaccine
August 6, 2020Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus
The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …
NICE advises GPs to stop prescribing opioids for chronic pain
August 5, 2020Business Services, Research and Development COVID-19, coronavirus
The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …
Pharmafile.com’s weekly COVID-19 news round-up
August 5, 2020Research and Development COVID-19, Weekly round up, coronavirus
The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …
EU agrees deal with Sanofi for COVID-19 vaccine supply
August 3, 2020Sales and Marketing COVID, COVID-19, coronavirus
The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow …
England to start using two new 90-minute COVID-19 tests in preparation for the winter
August 3, 2020Sales and Marketing COVID-19, coronavirus
Two new coronavirus tests are set to be made available throughout England that are significantly faster than most already in …
US Government commits $2.1bn to GSK and Sanofi’s COVID-19 vaccine candidate
July 31, 2020Medical Communications, Research and Development COVID-19, GSK, Sanofi, US, Vaccine
The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
